These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 26576710)

  • 1. Tanezumab Reduces Pain in Women with Interstitial Cystitis/Bladder Pain Syndrome and Patients with Nonurological Associated Somatic Syndromes.
    Nickel JC; Mills IW; Crook TJ; Jorga A; Smith MD; Atkinson G; Krieger JN
    J Urol; 2016 Apr; 195(4 Pt 1):942-8. PubMed ID: 26576710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary assessment of safety and efficacy in proof-of-concept, randomized clinical trial of tanezumab for chronic prostatitis/chronic pelvic pain syndrome.
    Nickel JC; Atkinson G; Krieger JN; Mills IW; Pontari M; Shoskes DA; Crook TJ
    Urology; 2012 Nov; 80(5):1105-10. PubMed ID: 23010344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clustering of Patients with Interstitial Cystitis/Bladder Pain Syndrome and Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
    Lai HH; Thu JHL; Moh FV; Paradis A; Vetter J
    J Urol; 2019 Sep; 202(3):546-551. PubMed ID: 30916629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between chronic nonurological associated somatic syndromes and symptom severity in urological chronic pelvic pain syndromes: baseline evaluation of the MAPP study.
    Krieger JN; Stephens AJ; Landis JR; Clemens JQ; Kreder K; Lai HH; Afari N; Rodríguez L; Schaeffer A; Mackey S; Andriole GL; Williams DA;
    J Urol; 2015 Apr; 193(4):1254-62. PubMed ID: 25444992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examination of the significant placebo effect in the treatment of interstitial cystitis/bladder pain syndrome.
    Bosch PC
    Urology; 2014 Aug; 84(2):321-6. PubMed ID: 24958479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Phase II Study of the Efficacy and Safety of the Novel Oral SHIP1 Activator AQX-1125 in Subjects with Moderate to Severe Interstitial Cystitis/Bladder Pain Syndrome.
    Nickel JC; Egerdie B; Davis E; Evans R; Mackenzie L; Shrewsbury SB
    J Urol; 2016 Sep; 196(3):747-54. PubMed ID: 26968644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo controlled trial of adalimumab for interstitial cystitis/bladder pain syndrome.
    Bosch PC
    J Urol; 2014 Jan; 191(1):77-82. PubMed ID: 23792149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratrigonal OnabotulinumtoxinA Improves Bladder Symptoms and Quality of Life in Patients with Bladder Pain Syndrome/Interstitial Cystitis: A Pilot, Single Center, Randomized, Double-Blind, Placebo Controlled Trial.
    Pinto RA; Costa D; Morgado A; Pereira P; Charrua A; Silva J; Cruz F
    J Urol; 2018 Apr; 199(4):998-1003. PubMed ID: 29031769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Painful Bladder Filling and Painful Urgency are Distinct Characteristics in Men and Women with Urological Chronic Pelvic Pain Syndromes: A MAPP Research Network Study.
    Lai HH; Krieger JN; Pontari MA; Buchwald D; Hou X; Landis JR;
    J Urol; 2015 Dec; 194(6):1634-41. PubMed ID: 26192257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome.
    Chuang YC; Kuo HC
    J Urol; 2017 Aug; 198(2):376-382. PubMed ID: 28202358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mental health diagnoses in patients with interstitial cystitis/painful bladder syndrome and chronic prostatitis/chronic pelvic pain syndrome: a case/control study.
    Clemens JQ; Brown SO; Calhoun EA
    J Urol; 2008 Oct; 180(4):1378-82. PubMed ID: 18707716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and psychological parameters associated with pain pattern phenotypes in women with interstitial cystitis/bladder pain syndrome.
    Nickel JC; Tripp DA;
    J Urol; 2015 Jan; 193(1):138-44. PubMed ID: 25092637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence and overlap of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome in men: results of the RAND Interstitial Cystitis Epidemiology male study.
    Suskind AM; Berry SH; Ewing BA; Elliott MN; Suttorp MJ; Clemens JQ
    J Urol; 2013 Jan; 189(1):141-5. PubMed ID: 23164386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fulranumab in patients with interstitial cystitis/bladder pain syndrome: observations from a randomized, double-blind, placebo-controlled study.
    Wang H; Russell LJ; Kelly KM; Wang S; Thipphawong J
    BMC Urol; 2017 Jan; 17(1):2. PubMed ID: 28056917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Randomized, Double-blind, Placebo-controlled Trial of Certolizumab Pegol in Women with Refractory Interstitial Cystitis/Bladder Pain Syndrome.
    Bosch PC
    Eur Urol; 2018 Nov; 74(5):623-630. PubMed ID: 30072210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pain and Urinary Symptoms Should Not be Combined into a Single Score: Psychometric Findings from the MAPP Research Network.
    Griffith JW; Stephens-Shields AJ; Hou X; Naliboff BD; Pontari M; Edwards TC; Williams DA; Clemens JQ; Afari N; Tu F; Lloyd RB; Patrick DL; Mullins C; Kusek JW; Sutcliffe S; Hong BA; Lai HH; Krieger JN; Bradley CS; Kim J; Landis JR
    J Urol; 2016 Apr; 195(4 Pt 1):949-54. PubMed ID: 26585679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability and Validity of Pain and Urinary Symptom Severity Assessment in Urological Chronic Pelvic Pain: A MAPP Network Analysis.
    Naliboff BD; Locke K; Schrepf AD; Griffith JW; Moldwin R; Krieger JN; Rodriguez LV; Clemens JQ; Lai HH; Sutcliffe S; Taple BJ; Williams D; Pontari MA; Mullins C; Landis JR
    J Urol; 2022 Jun; 207(6):1246-1255. PubMed ID: 35060778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proof of concept trial of tanezumab for the treatment of symptoms associated with interstitial cystitis.
    Evans RJ; Moldwin RM; Cossons N; Darekar A; Mills IW; Scholfield D
    J Urol; 2011 May; 185(5):1716-21. PubMed ID: 21420111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the SHIP1 Pathway Fails to Show Treatment Benefit in Interstitial Cystitis/Bladder Pain Syndrome: Lessons Learned from Evaluating Potentially Effective Therapies in This Enigmatic Syndrome.
    Nickel JC; Moldwin R; Hanno P; Dmochowski R; Peters KM; Payne C; Wein A
    J Urol; 2019 Aug; 202(2):301-308. PubMed ID: 31090511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bladder Instillations With Triamcinolone Acetonide for Interstitial Cystitis-Bladder Pain Syndrome: A Randomized Controlled Trial.
    Cardenas-Trowers OO; Abraham AG; Dotson TK; Houlette BA; Gaskins JT; Francis SL
    Obstet Gynecol; 2021 May; 137(5):810-819. PubMed ID: 33831942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.